JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB267232

Human UBE2G1 knockout HEK-293T cell line

Be the first to review this product! Submit a review

|

(0 Publication)

UBE2G1 KO cell line available to order. KO validated by. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp deletion in exon 2.

View Alternative Names

E217K, UB2G1_HUMAN, UBC 7, UBC7 homolog yeast, UBE 2G, Ube2g1, Ubiquitin carrier protein G1, Ubiquitin conjugating enzyme E2G 1 (UBC7 homolog C. elegans), Ubiquitin conjugating enzyme E2G 1 (UBC7 homolog yeast), Ubiquitin conjugating enzyme E2G 1 (homologous to C. elegans UBC7), Ubiquitin-conjugating enzyme E2 G1, Ubiquitin-protein ligase G1

1 Images
Sanger Sequencing - Human UBE2G1 knockout HEK-293T cell line (AB267232)
  • Sanger seq

Unknown

Sanger Sequencing - Human UBE2G1 knockout HEK-293T cell line (AB267232)

Homozygous : 1 bp deletion in exon2

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp deletion in exon 2

Product details

Recommended control: Human wild-type HEK293T cell line (ab255449). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab267232-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab267232 Human UBE2G1 knockout HEK-293T cell line", "number":"AB267232-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab267232-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab267232 Human UBE2G1 knockout HEK-293T cell line", "number":"AB267232-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
UBE2G1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Ube2G1 also known as ubiquitin-conjugating enzyme E2 G1 plays an important role in the ubiquitination process. This protein with a molecular mass of about 23 kDa is involved in tagging substrates with ubiquitin for proteasomal degradation—an important cellular mechanism that regulates protein levels and quality. Ube2G1 expresses in various tissues including the liver and central nervous system highlighting its broad role in maintaining cellular functions.
Biological function summary

Ube2G1's primary function supports protein homeostasis and cellular stress responses. It collaborates with E3 ubiquitin ligases in a complex to mediate the transfer of ubiquitin molecules to their targets. This activity is essential in controlling various cellular processes such as cell cycle regulation DNA repair and signal transduction. By participating in these functions Ube2G1 assures that the cellular environment remains stable and efficient.

Pathways

Ube2G1 has pivotal involvement in the ubiquitin-proteasome pathway which is significant for the regulated degradation of misfolded or damaged proteins. Additionally it interacts with components of the endoplasmic reticulum-associated degradation (ERAD) pathway working alongside proteins like Derlin-1 to eliminate faulty proteins from the ER. Through these pathways Ube2G1 contributes to cellular health by preventing protein aggregation and dysfunction.

Improper function of Ube2G1 can have serious implications for neurological conditions such as Alzheimer's disease due to the accumulation of misfolded proteins. Additionally cancer progression is linked to disruptions in protein degradation mechanisms involving Ube2G1 as it influences cell cycle and apoptosis. In cancer Ube2G1 can interact with tumor suppressor proteins like p53 affecting their stability and activity.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com